Toggle navigation
Home
Search
Services
Blog
Contact
About
MTN-017 A Phase 2 Randomized Study of Tenofovir &Truvada
National Institute of Allergy and Infectious Diseases
Search grants from National Institute of Allergy and Infectious Diseases
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of CD8+ T cell immunity to tuberculosis (pending title)
Genetics of water balance
Mindfulness-Based Relapse Prevention: Efficacy and Mechanisms
Biophysical limitations to signal transmission in the mammalian retina
Antileukemia Activity of Perillyl Alcohol
Recently added grants:
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
Hemolysis and Platelet Activation during Continuous Flow Mechanical Circulatory Support
Defining and Controlling Airway Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
NIH Inter-Agency Agreements (Y01)
Project #
AAI12043001-1-0-1
Application #
8654969
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$172,945
Indirect Cost
Institution
Name
National Institute of Allergy and Infectious Diseases
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2013
Y01 AI
MTN-017 A Phase 2 Randomized Study of Tenofovir &Truvada
/ National Institute of Allergy and Infectious Diseases
$172,945
NIH 2012
Y01 AI
MTN-017 A Phase 2 Randomized Study of Tenofovir &Truvada
/ National Institute of Allergy and Infectious Diseases
$50,000
Comments
Be the first to comment on this grant